Quantitative Sputum Cell Counts to Monitor Bronchitis: a Qualitative Study of Physician and Patient Perspectives

Overview

Journal Can Respir J

Publisher Wiley

Specialty Pulmonary Medicine

Date 2013 Mar 5

PMID 23457675

Citations 4

Authors

Liesel Dsilva

Helen Neighbour

Amiram Gafni

Katherine Radford

Freddy Hargreave

Parameswaran Nair

Affiliations

Soon will be listed here.

Abstract

Many common diseases affecting the airways are characterized by airway inflammation. The measurement of this inflammation has a significant role in the management of these diseases. Quantitative sputum cell counts provide a measurement of the type and severity of inflammation present. Sputum cell counts are used in routine clinical practice in some centres but their use is not widespread. The present study used a standardized questionnaire to determine both patients' and physicians' attitudes toward the use of sputum cell counts. The use of sputum cell counts was well accepted by patients and physicians. Ninety per cent of patients were satisfied with the test. Sixty per cent of family physicians were satisfied with the test and 80% were in favour of it being funded by the government. The authors recommend more widespread use of sputum cell counts to guide the management of airway diseases.

Citing Articles

Asthma Endotypes and an Overview of Targeted Therapy for Asthma.

Svenningsen S, Nair P Front Med (Lausanne). 2017; 4:158.

PMID: 29018800 PMC: 5622943. DOI: 10.3389/fmed.2017.00158.

Sputum cell counts to manage prednisone-dependent asthma: effects on FEV and eosinophilic exacerbations.

Aziz-Ur-Rehman A, Dasgupta A, Kjarsgaard M, Hargreave F, Nair P Allergy Asthma Clin Immunol. 2017; 13:17.

PMID: 28396690 PMC: 5379704. DOI: 10.1186/s13223-017-0190-0.

Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia.

Nair P, Ochkur S, Protheroe C, Radford K, Efthimiadis A, Lee N Allergy. 2013; 68(9):1177-84.

PMID: 23931643 PMC: 3788081. DOI: 10.1111/all.12206.

Update on clinical inflammometry for the management of airway diseases.

Nair P Can Respir J. 2013; 20(2):117-20.

PMID: 23616969 PMC: 3630046. DOI: 10.1155/2013/602936.

References

Taylor D, Pijnenburg M, Smith A, de Jongste J . Exhaled nitric oxide measurements: clinical application and interpretation. Thorax. 2006; 61(9):817-27. PMC: 2117092. DOI: 10.1136/thx.2005.056093. View

Heiner M . Key barriers to optimal management of adult asthma in Australia: physician and patient perspectives. Curr Med Res Opin. 2007; 23(8):1799-807. DOI: 10.1185/030079907X210714. View

Speight J, Barendse S . FDA guidance on patient reported outcomes. BMJ. 2010; 340:c2921. DOI: 10.1136/bmj.c2921. View

Jayaram L, Pizzichini M, Cook R, Boulet L, Lemiere C, Pizzichini E . Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J. 2006; 27(3):483-94. DOI: 10.1183/09031936.06.00137704. View

Brightling C . Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 Suppl):116S-121S. DOI: 10.1378/chest.129.1_suppl.116S. View

Leung G, Ho L, Chan M, M Johnston J, Wong F . The effects of cash and lottery incentives on mailed surveys to physicians: a randomized trial. J Clin Epidemiol. 2002; 55(8):801-7. DOI: 10.1016/s0895-4356(02)00442-0. View

Hargreave F . Quantitative sputum cell counts as a marker of airway inflammation in clinical practice. Curr Opin Allergy Clin Immunol. 2007; 7(1):102-6. DOI: 10.1097/ACI.0b013e328013e3c2. View

Brightling C . Clinical applications of induced sputum. Chest. 2006; 129(5):1344-8. DOI: 10.1378/chest.129.5.1344. View

OByrne P, Parameswaran K . Pharmacological management of mild or moderate persistent asthma. Lancet. 2006; 368(9537):794-803. DOI: 10.1016/S0140-6736(06)69289-1. View

10.

Anderson G . Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008; 372(9643):1107-19. DOI: 10.1016/S0140-6736(08)61452-X. View

11.

Bel E, Sousa A, Fleming L, Bush A, Chung K, Versnel J . Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax. 2010; 66(10):910-7. DOI: 10.1136/thx.2010.153643. View

12.

Barr R, Celli B, Martinez F, Ries A, Rennard S, Reilly Jr J . Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med. 2005; 118(12):1415. DOI: 10.1016/j.amjmed.2005.07.059. View

13.

Hargreave F, Parameswaran K . Asthma, COPD and bronchitis are just components of airway disease. Eur Respir J. 2006; 28(2):264-7. DOI: 10.1183/09031936.06.00056106. View

14.

Peters S . Counterpoint: Is measuring sputum eosinophils useful in the management of severe asthma? No, not for the vast majority of patients. Chest. 2011; 139(6):1273-1275. DOI: 10.1378/chest.11-0627. View

15.

Chow A, Mayer E, Darzi A, Athanasiou T . Patient-reported outcome measures: the importance of patient satisfaction in surgery. Surgery. 2009; 146(3):435-43. DOI: 10.1016/j.surg.2009.03.019. View

16.

Bousquet J, Mantzouranis E, Cruz A, Ait-Khaled N, Baena-Cagnani C, Bleecker E . Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol. 2010; 126(5):926-38. DOI: 10.1016/j.jaci.2010.07.019. View

17.

Kaner E, Haighton C, McAvoy B . 'So much post, so busy with practice--so, no time!': a telephone survey of general practitioners' reasons for not participating in postal questionnaire surveys. Br J Gen Pract. 1998; 48(428):1067-9. PMC: 1410021. View

18.

Kennedy W, Girard F, Chaboillez S, Cartier A, Cote J, Hargreave F . Cost-effectiveness of various diagnostic approaches for occupational asthma. Can Respir J. 2007; 14(5):276-80. PMC: 2676393. DOI: 10.1155/2007/206519. View

19.

Kraai I, Luttik M, De Jong R, Jaarsma T, Hillege H . Heart failure patients monitored with telemedicine: patient satisfaction, a review of the literature. J Card Fail. 2011; 17(8):684-90. DOI: 10.1016/j.cardfail.2011.03.009. View

20.

Hadji P . Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy. Crit Rev Oncol Hematol. 2009; 73(2):156-66. DOI: 10.1016/j.critrevonc.2009.02.001. View